2701 - 2710 of 7939 Results
Title
Year
-
OPENTitle: Predictors of cognitive impairment in primary age-related tauopathy: an autopsy studyJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-021-01233-3Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-021-01233-3Citation Count: 40
-
RESTRICTEDTitle: RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson’s diseaseJournal Name: Nature AgingPublisher: Springer Science and Business Media LLCVol: 1Issue #: 8Start Page: 734End Page: 747Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s43587-021-00088-6Citation Count: 32
-
OPENTitle: Generative image transformer (GIT): unsupervised continuous image generative and transformable model for [123I]FP-CIT SPECT imagesJournal Name: Annals of Nuclear MedicinePublisher: Springer Science and Business Media LLCVol: 35Issue #: 11Start Page: 1203End Page: 1213Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12149-021-01661-0Best OA location URL: https://repository.kulib.kyoto-u.ac.jp/dspace/bitstream/2433/275147/1/dnikk00096.pdfCitation Count: 8
-
OPENTitle: Native Separation and Metallation Analysis of SOD1 Protein from the Human Central Nervous System: a Methodological WorkflowJournal Name: Analytical ChemistryPublisher: American Chemical Society (ACS)Vol: 93Issue #: 32Start Page: 11108End Page: 11115Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acs.analchem.1c01128Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.analchem.1c01128Citation Count: 6
-
OPENTitle: Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in miceJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.67604Best OA location URL: https://doi.org/10.7554/elife.67604Citation Count: 72
-
OPENTitle: Sex differences in brain atrophy and cognitive impairment in Parkinson’s disease patients with and without probable rapid eye movement sleep behavior disorderJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 3Start Page: 1591End Page: 1599Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-021-10728-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-021-10728-x.pdfCitation Count: 25
-
OPENTitle: Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disordersJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 93Issue #: 1Start Page: 24End Page: 31Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2021-326904Best OA location URL: https://hal.sorbonne-universite.fr/hal-03471111/documentCitation Count: 79
-
OPENTitle: Assessing the Quality and Reliability of COVID-19 Information on Patient Organization WebsitesJournal Name: Frontiers in CommunicationPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcomm.2021.716683Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcomm.2021.716683/pdfCitation Count: 7
-
RESTRICTEDTitle: Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic EfficacyJournal Name:Publisher:Vol:Issue #:Start Page: 1306End Page: 1321Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.0c00162;Citation Count: 9
-
OPENTitle: Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic EfficacyJournal Name: ACS Pharmacology & Translational SciencePublisher: American Chemical Society (ACS)Vol: 4Issue #: 4Start Page: 1306End Page: 1321Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.0c00162Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369681Citation Count: 13